![]() |
市场调查报告书
商品编码
1898065
机械血栓切除装置市场规模、份额和成长分析(按产品类型、应用、最终用户和地区划分)—产业预测(2026-2033 年)Mechanical Thrombectomy Devices Market Size, Share, and Growth Analysis, By Product Type (Aspiration Catheters, Stent Retrievers), By Application (Ischemic Stroke, Pulmonary Embolism (PE)), By End-user, By Region - Industry Forecast 2026-2033 |
||||||
全球机械血栓切除装置市场规模预计在 2024 年达到 17.7 亿美元,从 2025 年的 19 亿美元成长到 2033 年的 32.8 亿美元,在预测期(2026-2033 年)内复合年增长率为 7.1%。
由于中风和血管疾病的发生率不断上升,全球机械取栓设备市场正经历强劲成长。微创医疗的趋势日益显着,这对取栓技术的发展产生了正面影响。机械取栓术是一种创伤较小的治疗选择,适用于血栓引起的缺血性中风等疾病,深受患者和医疗机构的青睐,因为他们希望透过这种手术改善治疗效果,同时减少创伤并促进康復。推动市场发展的关键因素包括技术创新、人口老化加剧以及医疗基础设施的持续改善。主要企业正积极致力于产品研发、临床试验和策略合作,以巩固其市场地位;然而,成本限制和认知度不足等挑战依然存在。对有效取栓解决方案的需求依然强劲,支撑着市场的持续成长。
全球机械血栓切除装置市场驱动因素
推动全球机械取栓装置市场成长的关键因素之一是中风(尤其是缺血性中风)发生率的上升。这些先进的装置在有效清除阻塞动脉中的血栓方面发挥关键作用,从而降低中风相关残疾和死亡的风险。随着世界人口老化以及高血压、糖尿病和肥胖等相关危险因子的盛行率不断上升,预计对机械取栓手术的需求将大幅增加。这一趋势凸显了这些装置在改善患者预后和提升公众健康整体的重要性。
限制全球机械血栓切除装置市场的因素
机械取栓装置的高成本对其广泛应用构成重大挑战。除了装置本身的成本外,手术相关的综合费用,包括住院和术后护理,都给医疗系统、保险公司和患者带来了经济负担。这种经济压力限制了患者获得这些重要疗法的机会,并最终可能阻碍机械血栓除去装置在临床实践中的广泛应用。因此,这些技术的潜在益处可能无法充分发挥,从而限制了其在血栓事件治疗中对患者预后的影响。
全球机械血栓切除装置市场趋势
受技术进步和产品创新的推动,全球机械取栓装置市场呈现强劲成长动能。製造商致力于开发高效、精准且微创的取栓解决方案,以改善患者预后。这一趋势包括改进装置设计、应用先进成像技术以及整合机器人和导航系统,从而提高手术的有效性和安全性。随着对有效中风治疗的医疗需求不断增长,这些创新不仅简化了流程,也顺应了个人化医疗的趋势,从而为该细分市场的持续增长和日益激烈的市场竞争奠定了基础。
Global Mechanical Thrombectomy Devices Market size was valued at USD 1.77 Billion in 2024 and is poised to grow from USD 1.9 Billion in 2025 to USD 3.28 Billion by 2033, growing at a CAGR of 7.1% during the forecast period (2026-2033).
The global market for mechanical thrombectomy devices is experiencing robust growth, driven by the increasing prevalence of stroke and vascular diseases. There is a notable shift towards minimally invasive healthcare practices, which is positively impacting thrombectomy techniques. Mechanical thrombectomy serves as a less invasive treatment alternative for conditions like ischemic stroke due to blood clots, appealing to both patients and healthcare providers seeking procedures that reduce trauma and accelerate recovery while delivering improved outcomes. Key market drivers include technological innovations, a growing elderly population, and advancements in healthcare infrastructure. Leading companies are actively focusing on product development, clinical trials, and strategic partnerships to strengthen their market positions, although challenges such as cost limitations and lack of awareness persist. The demand for effective clot removal solutions remains strong, fueling continued market growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mechanical Thrombectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Mechanical Thrombectomy Devices Market Segments Analysis
Global Mechanical Thrombectomy Devices Market is segmented by Product Type, Application, End-user and region. Based on Product Type, the market is segmented into Aspiration Catheters, Coil Retrievers, Stent Retrievers, and Other Devices. Based on Application, the market is segmented into Ischemic Stroke, Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT). Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Mechanical Thrombectomy Devices Market
One of the key factors propelling the growth of the global mechanical thrombectomy devices market is the increasing occurrence of strokes, especially ischemic strokes. These advanced devices play a crucial role in efficiently extracting blood clots from obstructed arteries, thereby mitigating the potential for disability and mortality linked to strokes. As the global population ages and the prevalence of associated risk factors, such as hypertension, diabetes, and obesity, grows, there is an anticipated surge in the demand for mechanical thrombectomy procedures. This trend highlights the importance of these devices in improving patient outcomes and overall public health.
Restraints in the Global Mechanical Thrombectomy Devices Market
The widespread adoption of mechanical thrombectomy devices faces significant challenges due to their high costs. The expenses associated with the devices, along with the comprehensive costs related to the procedures, such as hospitalization and post-operative care, create financial hurdles for health systems, insurance providers, and patients. This financial burden can restrict access to these critical interventions, ultimately hindering the growth and utilization of mechanical thrombectomy devices in clinical practice. As a result, the potential benefits of these technologies may not be fully realized, limiting their impact on patient outcomes in the treatment of thrombotic events.
Market Trends of the Global Mechanical Thrombectomy Devices Market
The Global Mechanical Thrombectomy Devices market is witnessing a robust trend driven by technological advancements and product innovation. Manufacturers are focusing on creating highly efficient, precise, and minimally invasive thrombectomy solutions that improve patient outcomes. This trend encompasses enhancements in device design, the incorporation of advanced imaging technologies, and the integration of robotic or navigation systems that elevate procedural effectiveness and safety. As healthcare demand for effective stroke treatments grows, these innovations not only streamline processes but also align with a broader shift towards personalized medicine, positioning the sector for sustained growth and enhanced market competitiveness.